146 related articles for article (PubMed ID: 7890505)
1. Histopathology, morphometry, and nuclear DNA content of iris melanocytic lesions.
Grossniklaus HE; Oakman JH; Cohen C; Calhoun FP; DeRose PB; Drews-Botsch C
Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):745-50. PubMed ID: 7890505
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
[TBL] [Abstract][Full Text] [Related]
3. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric DNA analysis of primary cutaneous malignant melanoma.
Ohnishi K; Ishikawa H
Acta Derm Venereol; 1991; 71(6):525-8. PubMed ID: 1685836
[TBL] [Abstract][Full Text] [Related]
5. Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi.
Kittler H; Pehamberger H; Wolff K; Binder M
J Am Acad Dermatol; 2000 Sep; 43(3):467-76. PubMed ID: 10954658
[TBL] [Abstract][Full Text] [Related]
6. Analysis of melanocytic lesions by DNA image cytometry.
Schmidt B; Weinberg DS; Hollister K; Barnhill RL
Cancer; 1994 Jun; 73(12):2971-7. PubMed ID: 8199994
[TBL] [Abstract][Full Text] [Related]
7. Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study.
von Roenn JH; Kheir SM; Wolter JM; Coon JS
Cancer Res; 1986 Jun; 46(6):3192-5. PubMed ID: 3698035
[TBL] [Abstract][Full Text] [Related]
8. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
[TBL] [Abstract][Full Text] [Related]
9. Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
van Poppelen NM; Vaarwater J; Mudhar HS; Sisley K; Rennie IG; Rundle P; Brands T; van den Bosch QCC; Mensink HW; de Klein A; Kiliç E; Verdijk RM
Ophthalmology; 2018 Jun; 125(6):904-912. PubMed ID: 29371009
[TBL] [Abstract][Full Text] [Related]
10. Examination of DNA-ploidy in melanocytic nevi cells using video-imaging cytometry.
Skowronek J; Filipiak K; Karaś Z; Krenz RM; Włodarczyk H
Pol J Pathol; 1997; 48(1):37-41. PubMed ID: 9200959
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy in malignant melanoma, skin cancer and pigmented nevi.
Skowronek J; Adamska K; Filipiak K; Karaś Z; Krenz RM; Rutkowski R; Warchoł JB
Neoplasma; 1997; 44(5):282-8. PubMed ID: 9473786
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic transvitreal fine-needle aspiration biopsy of small melanocytic choroidal tumors in nevus versus melanoma category.
Augsburger JJ; Corrêa ZM; Schneider S; Yassin RS; Robinson-Smith T; Ehya H; Trichopoulos N
Trans Am Ophthalmol Soc; 2002; 100():225-32; discussion 232-4. PubMed ID: 12545696
[TBL] [Abstract][Full Text] [Related]
13. Dermoscopic monitoring of melanocytic skin lesions: clinical outcome and patient compliance vary according to follow-up protocols.
Argenziano G; Mordente I; Ferrara G; Sgambato A; Annese P; Zalaudek I
Br J Dermatol; 2008 Aug; 159(2):331-6. PubMed ID: 18510663
[TBL] [Abstract][Full Text] [Related]
14. Morphometric, DNA, and proliferating cell nuclear antigen measurements in benign melanocytic lesions and cutaneous malignant melanoma.
Björnhagen V; Bonfoco E; Brahme EM; Lindholm J; Auer G
Am J Dermatopathol; 1994 Dec; 16(6):615-23. PubMed ID: 7864299
[TBL] [Abstract][Full Text] [Related]
15. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
Fullen DR; Zhu W; Thomas D; Su LD
J Cutan Pathol; 2005 Nov; 32(10):680-4. PubMed ID: 16293180
[TBL] [Abstract][Full Text] [Related]
16. Recurrent pigmented melanocytic nevus. A benign lesion, not to be mistaken for malignant melanoma.
Sexton M; Sexton CW
Arch Pathol Lab Med; 1991 Feb; 115(2):122-6. PubMed ID: 1992976
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool.
Bauer J; Bastian BC
Dermatol Ther; 2006; 19(1):40-9. PubMed ID: 16405569
[TBL] [Abstract][Full Text] [Related]
18. Relative frequency of solitary melanocytic lesions of the oral mucosa.
Buchner A; Merrell PW; Carpenter WM
J Oral Pathol Med; 2004 Oct; 33(9):550-7. PubMed ID: 15357676
[TBL] [Abstract][Full Text] [Related]
19. T1799A BRAF mutations in conjunctival melanocytic lesions.
Goldenberg-Cohen N; Cohen Y; Rosenbaum E; Herscovici Z; Chowers I; Weinberger D; Pe'er J; Sidransky D
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3027-30. PubMed ID: 16123397
[TBL] [Abstract][Full Text] [Related]
20. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization.
Busam KJ; Fang Y; Jhanwar SC; Pulitzer MP; Marr B; Abramson DH
J Cutan Pathol; 2010 Feb; 37(2):196-203. PubMed ID: 20100177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]